ERIC SPOHN: Open Payments
NPI 1104580711 · PLYMOUTH, IN. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$486 in 18 payments from 5 companies in 2025. Trend: 2023 $757 · 2024 $141 · 2025 $486
Food & beverage: $376Education: $109
| Company | Payments | Amount |
|---|---|---|
| E.R. Squibb & Sons, L.L.C. | 9 | $238 |
| Teva Pharmaceuticals USA, Inc. | 4 | $148 |
| Axsome Therapeutics, Inc. | 2 | $47 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 2 | $35 |
| Alkermes, Inc. | 1 | $18 |
Products named: COBENFY, Auvelity, UZEDY, CAPLYTA, LYBALVI.
Industry payments across IN — which companies pay providers there.
